Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
Use this PTHS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PTHS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PTHS SEC filings page. Lician reads the product cache first so this HTML stays unique to Pelthos Therapeutics Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full PTHS income, balance, and cash tables.